Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Alpelisib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Neoplasm Metastasis 3 Recurrence 2 Ovarian Neoplasms 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Hereditary Sensory and Autonomic Neuropathies 2 Vascular Malformations 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases, Vascular 1 Hyperglycemia 1 Hormone Receptor Positive Breast Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Arteriovenous Malformations 1 Advanced HER2+Breast Cancer 1 Advanced Breast Cancer 1

Interventions

Cisplatin 11 pembrolizumab 8 Paclitaxel 7 Drug Therapy 6 Irinotecan 4 Fluorouracil 4 Carboplatin 4 toripalimab 3 Radiotherapy 3 tislelizumab 2 nimotuzumab 2 Oxaliplatin 2 Nivolumab 2 Levoleucovorin 2 Leucovorin 2 Docetaxel 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 regorafenib 1 osimertinib 1 nedaplatin 1 lenvatinib 1 futibatinib 1 durvalumab 1 camrelizumab 1 atezolizumab 1 aflibercept 1 Tiragolumab 1 Surgical Procedures, Operative 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡